Commentary: Gut Microbiota and Brain Function: A New Target for Brain Diseases?

E-ISSN： 1996-3181|13|5|733-735

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.5, 2014-06, pp. : 733-735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The brain as a target for development of new class of drugs for the treatment of somatic diseases

By Mravec Boris

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 433-437

Informa Healthcare

Access to resources Recommend Favorite

Ghrelin and the Brain-gut Axis as a Pharmacological Target for Appetite Control

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 768-775

Bentham Science Publishers

Access to resources Recommend Favorite

Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases

Current Medicinal Chemistry, Vol. 25, Iss. 32, 2018-10 ,pp. : 3930-3952

Bentham Science Publishers

Access to resources Recommend Favorite

Gut Microbiota as a Therapeutic Target for Metabolic Disorders

Current Medicinal Chemistry, Vol. 25, Iss. 9, 2018-03 ,pp. : 984-1001

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Gut Microbiota and Gastrointestinal Diseases: To Treat or Not to Treat

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4533-4534

Bentham Science Publishers

Access to resources Recommend Favorite